3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Diabetes -

Diabetics’ blood pressure often inadequately controlled

DiabetesMay 21, 08

Uncertainty about a patient’s “true” blood pressure (BP) is the chief reason why doctors fail to intensify BP-lowering treatment when a diabetic patient has high BP (hypertension), investigators report.

“Several studies have suggested that ‘clinical inertia’—the failure by providers to initiate or intensify therapy n the face of apparent need to do so—is a main contributor to poor control of hypertension,” Dr. Eve A. Kerr and colleagues explain in a report in the Annals of Internal Medicine.

To identify factors that underlie “clinical inertia,” Kerr at the Veterans Affairs Ann Arbor Healthcare System in Michigan and her team studied 1,169 diabetic patients with hypertension seen by 92 primary care doctors at 9 VA facilities.

Before the study, all the patients were found to have high BP (140/90 mm Hg). Normal BP is anything below 120/80 mm/Hg.

However, despite substantially elevated BP, medication was intensified or close follow-up was scheduled for just 49 percent of the patients.

“Clinical uncertainty” about the true BP value was a prominent reason that providers did not intensify therapy, the investigators found. Specifically, they were less likely to adjust medication if they themselves recorded a BP measurement of less than 140/90 versus a higher reading during the visit, or when patients reported that their BP readings at home were less than 140/90 rather than higher.

“Unfortunately,” primary care doctors are not consistent in their approach to gauging “real” BP, and are “possibly placing undue faith in their own repeated measurements or home blood pressure values,” the investigators write.

“This ambiguous approach ... may be a major obstacle to optimizing management of hypertension and improving outcomes for high-risk populations,” they conclude.

SOURCE: Annals of Internal Medicine, May 20, 2008.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  New superfoods could help key protein keep bodies healthy
  Poor quality of life may affect teens’ diabetes management
  Cancer drug protects against diabetes
  Amino acid’s increase is suspected in diabetes
  New Type 2 Diabetes Drug Onglyza Approved
  Mail order pharmacy use safe for people with diabetes
  Policy considerations pose options for leaders to reduce costly disparities in diabetes
  Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery
  Obesity-Linked Diabetes in Children Resists Treatment
  Diabetes again linked to colon cancer risk

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site